Interleukin-19 acts as a negative autocrine regulator of activated microglia

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Horiuchi, Hiroshi ^a   Parajuli, Bijay ^a   Wang, Yue ^a   Azuma, Yasu Taka ^b   Mizuno, Tetsuya ^a   Takeuchi, Hideyuki ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CD11B ANTIGEN; COMPLEMENTARY DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 19 RECEPTOR; INTERLEUKIN 20; INTERLEUKIN 20 RECEPTOR ALPHA; INTERLEUKIN 20 RECEPTOR BETA; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; INTERLEUKIN 6; MESSENGER RNA; ORGANIC ANION TRANSPORTER B; PROSTAGLANDIN E SYNTHASE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE RECEPTOR; IL19 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DNA MICROARRAY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MICROGLIA; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RESTING STATE NETWORK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; AUTOCRINE COMMUNICATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; RECEPTORS, CYTOKINE; UP-REGULATION;

EID: 84925617956     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118640     Document Type: Article

References (49)

1. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8(1): 57-69. PMID: 17180163
2. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol. 2013; 39(1): 3-18. doi: 10.1111/nan.12011 PMID: 23252647
3. Kempermann G, Neumann H. Neuroscience. Microglia: the enemy within? Science. 2003; 302(5651): 1689-1690. PMID: 14657479
4. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996; 19(8): 312-318. PMID: 8843599
5. Takeuchi H. Neurotoxicity by microglia: Mechanisms and potential therapeutic strategy. Clin Exp Neuroimmunol. 2010; 1(1): 12-21.
6. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723-749. PMID: 15217349
7. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001; 358(9280): 461-467. PMID: 11513911
8. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia. 2002; 40(2): 232-239. PMID: 12379910
9. McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002; 26(4): 459-470. PMID: 12362410
10. Nelson PT, Soma LA, Lavi E. Microglia in diseases of the central nervous system. Ann Med. 2002; 34 (7-8): 491-500. PMID: 12553496
11. Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson's disease. Prog Neurobiol. 2002; 68(5): 325-340. PMID: 12531233
12. Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology. 2006; 66(11): 1638-1643. PMID: 16769933
13. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, et al. Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci. 2008; 28(45): 11650-11661. doi: 10.1523/JNEUROSCI.3024-08.2008 PMID: 18987201
14. Nakanishi H,Wu Z. Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav Brain Res. 2009; 201(1): 1-7. doi: 10.1016/j.bbr.2009.02.001 PMID: 19428609
15. Sawada M. Neuroprotective and toxic changes in microglia in neurodegenerative disease. Parkinsonism Relat Disord. 2009; 15 Suppl 1: S39-41. doi: 10.1016/S1353-8020(09)70011-2 PMID: 19131042
16. Wu Z, Tokuda Y, Zhang XW, Nakanishi H. Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol Dis. 2008; 32(3): 543-551. doi: 10.1016/j.nbd.2008.09.002 PMID: 18848892
17. Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem. 1999; 72(4): 1466-1471. PMID: 10098850
18. Sabat R, Wallace E, Endesfelder S, Wolk K. IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases. Expert Opin Ther Targets. 2007; 11(5): 601-612. PMID: 17465720
19. Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends Immunol. 2002; 23(2): 89-96. PMID: 11929132
20. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol. 2001; 167(7): 3545-3549. PMID: 11564763
21. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem. 2002; 277(49): 47517-47523. PMID: 12351624
22. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNFalpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002; 169(8): 4288-4297. PMID: 12370360
23. Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, Yu CK, et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol. 2004; 173(11): 6712-6718. PMID: 15557163
24. Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, Kaneko Y, et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford). 2008; 47 (6): 815-820. doi: 10.1093/rheumatology/ken061 PMID: 18397956
25. Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, et al. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis. 2010; 16(6): 1017-1028. doi: 10.1002/ibd.21151 PMID: 19834971
26. Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, et al. IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation. Am J Pathol. 2014; 184(7): 2134-2143. doi: 10.1016/j.ajpath.2014.04.001 PMID: 24814101
27. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997; 19(4): 939-945. PMID: 9354339
28. Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, et al. Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease. PLoS One. 2011; 6(6): e21108. doi: 10.1371/journal.pone.0021108 PMID: 21712989
29. Suzumura A, Mezitis SG, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated mac-rophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J Neuroimmunol. 1987; 15(3): 263-278. PMID: 3110208
30. Liang J, Takeuchi H, Doi Y, Kawanokuchi J, Sonobe Y, Jin S, et al. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity. Brain Res. 2008; 1210: 11-19. doi: 10.1016/j.brainres.2008.03.012 PMID: 18410911
31. Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, et al. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem. 2005; 280(11): 10444-10454. PMID: 15640150
32. Doi Y, Takeuchi H, Horiuchi H, Hanyu T, Kawanokuchi J, Jin S, et al. Fingolimod phosphate attenuates oligomeric amyloid beta-induced neurotoxicity via increased brain-derived neurotrophic factor expression in neurons. PLoS One. 2013; 8(4): e61988. doi: 10.1371/journal.pone.0061988 PMID: 23593505
33. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 2006; 281(30): 21362-21368. PMID: 16720574
34. Cooley ID, Chauhan VS, Donneyz MA, Marriott I. Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member. Glia. 2014; 62(5): 818-828. PMID: 24677051
35. Preimel D, Sticht H. Molecular modeling of the interleukin-19 receptor complex. Novel aspects of receptor recognition in the interleukin-10 cytokine family. J Mol Model. 2004; 10(4): 290-296. PMID: 15243778
36. Menon R, Ismail L, Ismail D, Merialdi M, Lombardi SJ, Fortunato SJ. Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production. J Matern Fetal Neonatal Med. 2006; 19(4): 209-214. PMID: 16854693
37. Hsing CH, Li HH, Hsu YH, Ho CL, Chuang SS, Lan KM, et al. The distribution of interleukin-19 in healthy and neoplastic tissue. Cytokine. 2008; 44(2): 221-228. doi: 10.1016/j.cyto.2008.06.007 PMID: 18809337
38. Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol. 2002; 168(11): 5397-5402. PMID: 12023331
39. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 2000; 1(7): 442-450. PMID: 11196675
40. Hsing CH, Hsieh MY, Chen WY, Cheung So E, Cheng BC, Chang MS. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg. 2006; 81(6): 2196-2201. PMID: 16731153
41. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS. IL-19 is involved in the pathogenesis of endotoxic shock. Shock. 2008; 29(1): 7-15. PMID: 18246602
42. Cuneo AA, Herrick D, Autieri MV. Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability. J Mol Cell Cardiol. 2010; 49(4): 647-654. doi: 10.1016/j. yjmcc.2010.04.016 PMID: 20451530
43. Takeuchi H, Suzumura A. Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases. Front Cell Neurosci. 2014; 8: 189. doi: 10.3389/fncel. 2014.00189 PMID: 25228858
44. Kawanokuchi J, Mizuno T, Takeuchi H, Kato H, Wang J, Mitsuma N, et al. Production of interferongamma by microglia. Mult Scler. 2006; 12(5): 558-564. PMID: 17086900
45. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, et al. Production and functions of IL-17 in microglia. J Neuroimmunol. 2008; 194(1-2): 54-61. doi: 10.1016/j.jneuroim.2007.11.018 PMID: 18295350
46. Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005; 1040(1-2): 202-207. PMID: 15804439
47. Wang X, Suzuki Y. Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. J Interferon Cytokine Res. 2007; 27(7): 599-605. PMID: 17651021
48. Orellana JA, Saez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, et al. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal. 2009; 11(2): 369-399. doi: 10.1089/ars.2008.2130 PMID: 18816186
49. Takeuchi H, Wang J, Kawanokuchi J, Mitsuma N, Mizuno T, Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol Dis. 2006; 22(1): 33-39. PMID: 16386911